Open an account

Avantor

AVTR · NYSE

$16.62+$0.33 (+2.03%)TodayMarket closed ·
Prev close $16.29

About AVTR

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

Employees
13,500
Headquarters
Radnor, Pennsylvania
Listed
May 17, 2019
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
avantorsciences.com

AVTR key statistics

Market cap
11.24B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
9.07M
Volume
9.15M
Open price
$16.38
High today
$16.83
Low today
$16.24
52 Week high
$16.55
52 Week low
$7.27

Avantor (AVTR) at a glance

Avantor (AVTR) last traded at $16.62, with a market cap of 11.24B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $16.24 and $16.83. The current price is 2.3% above the day's low and 1.2% below its high.

Volume so far is 9.15M shares, in line with the average of 9.07M shares a day.

Over the past year Avantor has ranged from $7.27 to $16.55, and now sits 101% of the way up that range.

Avantor met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.21 per share against an estimate of $0.1934.

The average analyst price target is $15.01, 9.7% below the current price, from 13 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

15%of 13 analyst ratings say Buy
  • Buy15.4%
  • Hold61.5%
  • Sell23.1%
Price target · 18 analystsAvg $15.01
Low
$13.13
Now
$16.62
High
$19.95

AVTR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 4.6% on average.

  1. Q3 FY24: reported $0.26 per share against an estimate of $0.2585
  2. Q4 FY24: reported $0.27 per share against an estimate of $0.2623
  3. Q1 FY25: reported $0.23 per share against an estimate of $0.2356
  4. Q2 FY25: reported $0.24 per share against an estimate of $0.2529
  5. Q3 FY25: reported $0.22 per share against an estimate of $0.2291
  6. Q4 FY25: reported $0.22 per share against an estimate of $0.2208
  7. Q1 FY26: reported $0.17 per share against an estimate of $0.1601
  8. Q2 FY26: reported $0.21 per share against an estimate of $0.1934

AVTR news

  • Press releasePRNewswire

    Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026

  • 10 Health Care Stocks With Whale Alerts In Today’s Session

  • Press releasePRNewswire

    Avantor appoints new Chief Financial Officer

  • Press releasePRNewswire

    Avantor® Reports Second Quarter 2026 Results

  • Press releasePRNewswire

    Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product

  • Press releasePRNewswire

    Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026

  • Press releasePRNewswire

    Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

  • Transcript: Avantor Q1 2026 Earnings Conference Call

Similar companies

Companies in the same industry as Avantor

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.